[Oxidative pulmonary stress in cytoreductive therapy].
Beinert
T
T
Medizinische Klinik und Poliklinik m. S. Hämatologie und Onkologie, Charité, Berlin.
Binder
D
D
Stuschke
M
M
Oehm
C
C
Jörres
R A
RA
Schweigert
M
M
Seemann
M
M
Mergenthaler
H G
HG
Behr
J
J
Fleischhacker
M
M
Possinger
K
K
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003131:Combined Modality Therapy; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000528:radiation effects; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D018384:Oxidative Stress / Q000187:drug effects / Q000528:radiation effects; D011878:Radiotherapy / Q000009:adverse effects*
D000970:Antineoplastic Agents
Oxidativer pulmonaler Stress unter zytoreduktiver Therapie.